Efficacy of a Novel Hemostatic Powder in GI Bleeding

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Gastrointestinal Bleeding
Interventions
OTHER

Non interventional study

All upper gastro-intestinal bleeding need endoscopic hemostasis. Endoscopic hemostasis conventional methods are injection of saline with epinephrine, placement of hemoclips and thermic or plasma coagulation. Hemospray™ will be sprayed onto bleeding lesions seen in endoscopy after failure of conventional methods or in salvage therapy at the discretion of endoscopists. Retrospective analysis of prospectively cellected data.

Trial Locations (19)

13005

La Conception University Hospital, Marseille

La Timone University Hospital, Marseille

22000

Saint-Brieuc University Hospital, Saint-Brieuc

25030

Besançon University Hospital, Besançon

30029

Nîmes University Hospital, Nîmes

31000

Clinique des Cèdres, Toulouse

33076

Bordeuax University Hospital, Bordeaux

37044

Tours University Hospital, Tours

44093

Nantes University Hospital, Nantes

49933

Angers University Hospital, Angers

59037

Lille University Hospital, Lille

75000

Cochin University Hospital, Paris

Georges Pompidou University Hospital (AP-HP), Paris

Henri Mondor University Hospital (AP-HP), Paris

Lariboisière University Hospital (AP-HP), Paris

76031

Rouen University Hospital, Rouen

87042

Limoges University Hospital, Limoges

98012

Monaco University Hospital, Monaco

03200

Vichy Hospital, Vichy

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02595853 - Efficacy of a Novel Hemostatic Powder in GI Bleeding | Biotech Hunter | Biotech Hunter